S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.18 CNY -1.64% Market Closed
Market Cap: 34.8B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Gross Margin
Shenzhen Salubris Pharmaceuticals Co Ltd

68.6%
Current
70%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
68.6%
=
Gross Profit
2.6B
/
Revenue
3.7B

Gross Margin Across Competitors

Country CN
Market Cap 34B CNY
Gross Margin
69%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 756.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 364.1B USD
Gross Margin
69%
Country US
Market Cap 248.4B USD
Gross Margin
77%
Country CH
Market Cap 208.5B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 159.6B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Shenzhen Salubris Pharmaceuticals Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
68.6%
=
Gross Profit
2.6B
/
Revenue
3.7B
What is the Gross Margin of Shenzhen Salubris Pharmaceuticals Co Ltd?

Based on Shenzhen Salubris Pharmaceuticals Co Ltd's most recent financial statements, the company has Gross Margin of 68.6%.